Neuroinflammation in Alzheimer’s disease

References

• SpencerJPEVafeiadouKWilliamsRJVauzourDNeuroinflammation: modulation by flavonoids and mechanisms of actionMol Aspects Med2012331839722107709
   PubMed Web of Science ®Google Scholar
• HensleyKNeuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulationJ Alzheimers Dis201021111420182045
   PubMed Web of Science ®Google Scholar
• McGeerEGMcGeerPLNeuroinflammation in Alzheimer’s disease and mild cognitive impairment: a field in its infancyJ Alzheimer Dis2010191355361
   PubMed Web of Science ®Google Scholar
• BrownGCBal-PriceAInflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondriaMol Neurobiol200327332535512845153
   PubMed Web of Science ®Google Scholar
• ArimaYKamimuraDSabharwalLRegulation of immune cell infiltration into the CNS by regional neural Inputs explained by the gate theoryMediators Inflamm2013201389816523990699
   PubMed Web of Science ®Google Scholar
• AbbottNJRönnbäckLHanssonEAstrocyte – endothelial interactions at the blood–brain barrierNat Rev Neurosci200671415316371949
   PubMed Web of Science ®Google Scholar
• MaedaTKandaTBlood–brain barrier and blood-nerve barrier in neuroinflammatory diseasesNippon Rinsho201371578979423777083
   PubMedGoogle Scholar
• SyvanenSErikssonJAdvances in PET imaging of P-glycoprotein function at the blood–brain barrierACS Chem Neurosci20134222523723421673
   PubMed Web of Science ®Google Scholar
• GheorghiuMEnciuA-MPopescuBOGheorghiuEFunctional and molecular characterization of the effect of amyloid-beta(42) on an in vitro epithelial barrier modelJ Alzheimers Dis201438478779824072066
   PubMed Web of Science ®Google Scholar
• BurgmansSvan de HaarHJVerheyFRJBackesWHAmyloid-beta interacts with blood–brain barrier function in dementia: a systematic reviewJ Alzheimers Dis201335485987323542866
   PubMed Web of Science ®Google Scholar
• SteinmanLInflammatory cytokines at the summits of pathological signal cascades in brain diseasesSci Signal20136258e3
   Web of Science ®Google Scholar
• CarranoAHoozemansJJMvan der ViesSMvan HorssenJde VriesHERozemullerAJMNeuroinflammation and blood–brain barrier changes in capillary amyloid angiopathyNeurodegene Dis2012101–4329331
   PubMed Web of Science ®Google Scholar
• RivestSLacroixSVallièresLNadeauSZhangJLaflammeNHow the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuliProc Soc Exp Biol Med20002231223810632958
   PubMed Web of Science ®Google Scholar
• TakedaSSatoNIkimuraKNishinoHRakugiHMorishitaRIncreased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse modelNeurobiol Aging20133482064207023561508
   PubMed Web of Science ®Google Scholar
• MischelevichDJInventorMISCHELEVICHDJ(MISC-Individual), assigneeMethod for altering permeability of blood–brain barrier in patient for use in treatment of eg., Alzheimer disease, involves energizing transducer to deliver pulsed ultrasound energy to target in brain or spinal cord US patent US2013079682-A12013328
   Google Scholar
• Serrano-PozoAMielkeMLGómez-IslaTReactive Glia not only associates with plaques but also parallels tangles in Alzheimer’s diseaseAm J Pathol201117931373138421777559
   PubMed Web of Science ®Google Scholar
• HenekaMTO’BanionMKInflammatory processes in Alzheimer’s diseaseJ Neuroimmunol20071841699117222916
   PubMed Web of Science ®Google Scholar
• CzehMGressensPKaindlAMThe yin and yang of microgliaDev Neurosci2011333–419920921757877
   PubMed Web of Science ®Google Scholar
• GinhouxFLimSHoeffelGLowDHuberTOrigin and differentiation of microgliaFront Cell Neurosci2013177
   Google Scholar
• GlassCKSaijoKWinnerBMarchettoMCGageFHMechanisms underlying inflammation in neurodegenerationCell2010140691893420303880
   PubMed Web of Science ®Google Scholar
• GreterMMeradMRegulation of microglia development and homeostasisGlia201361112112722927325
   PubMed Web of Science ®Google Scholar
• BlockMLZeccaLHongJ-SMicroglia-mediated neurotoxicity: uncovering the molecular mechanismsNat Rev Neurosci200781576917180163
   PubMed Web of Science ®Google Scholar
• HarryGJKraftADMicroglia in the developing brain: a potential target with lifetime effectsNeurotoxicology201233219120622322212
   PubMed Web of Science ®Google Scholar
• MoralesIJimenezJMMancillaMMaccioniRBTau oligomers and fibrils induce activation of microglial cellsJ Alzheimers Dis201337484985623948931
   PubMed Web of Science ®Google Scholar
• RodriguezJJWittonJOlabarriaMNoristaniHNVerkhratskyAIncrease in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer’s diseaseCell Death Dis20101e121364611
   PubMed Web of Science ®Google Scholar
• GriciucASerrano-PozoAParradoARAlzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid betaNeuron201378463164323623698
   PubMed Web of Science ®Google Scholar
• SchefflerKStenzelJKrohnMDetermination of spatial and temporal distribution of microglia by 230 nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer’s diseaseCurr Alzheimer Res20118778178821244350
   PubMed Web of Science ®Google Scholar
• Du YanSChenXFuJRAGE and amyloid-β peptide neurotoxicity in Alzheimer’s diseaseNature199638265936856918751438
   PubMed Web of Science ®Google Scholar
• El KhouryJHickmanSThomasCLoikeJSilversteinSMicroglia, scavenger receptors, and the pathogenesis of Alzheimer’s diseaseNeurobiol Aging1998191S81S849562474
   PubMed Web of Science ®Google Scholar
• LeissringMAFarrisWChangAYEnhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature deathNeuron20034061087109314687544
   PubMed Web of Science ®Google Scholar
• LiWPoteetEXieLLiuRWenYYangS-HRegulation of matrix metalloproteinase 2 by oligomeric amyloid β proteinBrain Res2011138714114821376707
   PubMed Web of Science ®Google Scholar
• LiuBHongJ-SRole of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic interventionJ Pharmacol Exp Ther200330411712490568
   PubMed Web of Science ®Google Scholar
• NaertGRivestSThe role of microglial cell subsets in Alzheimer’s diseaseCurr Alzheimer Res20118215115521418002
   PubMed Web of Science ®Google Scholar
• HickmanSEAllisonEKEl KhouryJMicroglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer’s disease miceJ Neurosci200828338354836018701698
   PubMed Web of Science ®Google Scholar
• FlodenAMCombsCKMicroglia demonstrate age-dependent interaction with amyloid-beta fibrilsJ Alzheimers Dis201125227929321403390
   PubMed Web of Science ®Google Scholar
• KrabbeGHalleAMatyashVFunctional impairment of micro-glia coincides with beta-amyloid deposition in mice with Alzheimer-like pathologyPLoS One201384e6092123577177
   PubMed Web of Science ®Google Scholar
• HanischUKKettenmannHMicroglia: active sensor and versatile effector cells in the normal and pathologic brainNat Neurosci200710111387139417965659
   PubMed Web of Science ®Google Scholar
• HenekaMTKummerMPStutzANLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceNature2012493743467467823254930
   PubMed Web of Science ®Google Scholar
• SherwoodCCStimpsonCDRaghantiMAEvolution of increased glia – neuron ratios in the human frontal cortexProc Natl Acad Sci U S A200610337136061361116938869
   PubMed Web of Science ®Google Scholar
• ChanWYKohsakaSRezaiePThe origin and cell lineage of microglia – new conceptsBrain Res Rev200753234435417188751
   PubMedGoogle Scholar
• MolofskyAVKrencikRUllianEMAstrocytes and disease: a neurodevelopmental perspectiveGenes Dev201226989190722549954
   PubMed Web of Science ®Google Scholar
• SunDJakobsTCStructural remodeling of astrocytes in the injured CNSNeuroscientist201218656758821982954
   PubMed Web of Science ®Google Scholar
• Sidoryk-WegrzynowiczMWegrzynowiczMLeeEBowmanABAschnerMRole of astrocytes in brain function and diseaseToxicol Pathol201139111512321075920
   PubMed Web of Science ®Google Scholar
• CarreroIGonzaloMRMartinBSanz-AnquelaJMArevalo-SerranoJGonzalo-RuizAOligomers of beta-amyloid protein (A beta 1–42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brainExp Neurol2012236221522722617488
   PubMed Web of Science ®Google Scholar
• MedeirosRLaFerlaFMAstrocytes: conductors of the Alzheimer disease neuroinflammatory symphonyExp Neurol201323913313823063604
   PubMed Web of Science ®Google Scholar
• CroweEBhatRBittoAAstrocyte senescence as a component of Alzheimer’s diseaseExp Gerontol2013487695696
   Web of Science ®Google Scholar
• BlaskoIVeerhuisRStampfer-KountchevMSaurwein-TeisslMEikelenboomPGrubeck-LoebensteinBCostimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1–40 and Abeta1–42 by human astrocytesNeurobiol Dis200076 pt B68268911114266
   PubMed Web of Science ®Google Scholar
• YuYHeJZhangYIncreased hippocampal neurogenesis in the progressive stage of Alzheimer’s disease phenotype in an APP/PS1 double transgenic mouse modelHippocampus200919121247125319309037
   PubMed Web of Science ®Google Scholar
• TangBLNeuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptorsCell Adh Migr20093111812819372755
   PubMed Web of Science ®Google Scholar
• Hartlage-RübsamenMZeitschelUApeltJAstrocytic expression of the Alzheimer’s disease β-secretase (BACE1) is stimulus-dependentGlia200341216917912509807
   PubMed Web of Science ®Google Scholar
• RoßnerSLange-DohnaCZeitschelUPerez-PoloJRAlzheimer’s disease β-secretase BACE1 is not a neuron-specific enzymeJ Neuro-chem2005922226234
   PubMed Web of Science ®Google Scholar
• WeggenSDiehlmannABusleiRBeyreutherKBayerTProminent expression of presenilin-1 in senile plaques and reactive astrocytes in Alzheimer’s disease brainNeuroreport1998914327932839831464
   PubMed Web of Science ®Google Scholar
• ZhaoJO’ConnorTVassarRThe contribution of activated astrocytes to A beta production: implications for Alzheimer’s disease pathogenesisJ Neuroinflammation201128
   Google Scholar
• MinersJSVan HelmondZKehoePGLoveSChanges with age in the activities of β-secretase and the Aβ-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzymeBrain Pathol201020479480220175776
   PubMed Web of Science ®Google Scholar
• ApeltJAchKSchliebsRAging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaquesNeurosci Lett2003339318318612633883
   PubMed Web of Science ®Google Scholar
• RosselloXSIgbavboaUWeismanGASunGYWoodWGAP-2 beta regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytesBrain Res20121444879522325097
   PubMed Web of Science ®Google Scholar
• RossiDVolterraAAstrocytic dysfunction: insights on the role in neurodegenerationBrain Res Bull200980422423219631259
   PubMed Web of Science ®Google Scholar
• QinHBenvenisteENELISA methodology to quantify astrocyte production of cytokines/chemokines in vitroMethods Mol Biol2012201281423524922144311
   PubMedGoogle Scholar
• TalantovaMSanz-BlascoSZhangXA beta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic lossProc Natl Acad Sci U S A201311027E2518E252723776240
   PubMed Web of Science ®Google Scholar
• BhatRCroweEPBittoAAstrocyte senescence as a component of Alzheimer’s diseasePLoS One201279e4506922984612
   PubMed Web of Science ®Google Scholar
• ThalDRThe role of astrocytes in amyloid beta-protein toxicity and clearanceExp Neurol201223611522575598
   PubMed Web of Science ®Google Scholar
• FurmanJLSamaDMGantJCTargeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer’s diseaseJ Neurosci20123246161291614023152597
   PubMed Web of Science ®Google Scholar
• KrishnaMNarangHThe complexity of mitogen-activated protein kinases (MAPKs) made simpleCell Mol Life Sci200865223525354418668205
   PubMed Web of Science ®Google Scholar
• WangXTournierCRegulation of cellular functions by the ERK5 signalling pathwayCell Signal200618675376016376520
   PubMed Web of Science ®Google Scholar
• KyriakisJMAvruchJMammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year updatePhysiol Rev201292268973722535895
   PubMed Web of Science ®Google Scholar
• GeritsNKostenkoSMoensUIn vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out miceTransgenic Res200716328131417219248
   PubMed Web of Science ®Google Scholar
• WagnerEFNebredaÁRSignal integration by JNK and p38 MAPK pathways in cancer developmentNat Rev Cancer20099853754919629069
   PubMed Web of Science ®Google Scholar
• OrejanaLBarros-MinonesLAguirreNPuertaEImplication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse modelExp Gerontol201348656557123501261
   PubMed Web of Science ®Google Scholar
• SclipAAntoniouXColomboAc-Jun N-terminal kinase regulates soluble A beta oligomers and cognitive impairment in AD mouse modelJ Biol Chem201128651438714388022033930
   PubMed Web of Science ®Google Scholar
• ShojiMIwakamiNTakeuchiSJNK activation is associated with intracellular β-amyloid accumulationMol Brain Res200085122123311146125
   PubMedGoogle Scholar
• LinWDingMXueJLengWThe role of TLR2/JNK/NF-kappa B pathway in amyloid beta peptide-induced inflammatory response in mouse NG108-15 neural cellsInt Immunopharmacol201317388088424126115
   PubMed Web of Science ®Google Scholar
• MunozLAmmitAJTargeting p38 MAPK pathway for the treatment of Alzheimer’s diseaseNeuropharmacology201058356156819951717
   PubMed Web of Science ®Google Scholar
• LeeYBSchraderJWKimSUp38 MAP kinase regulates TNF-α production in human astrocytes and microglia by multiple mechanismsCytokine200012787488010880231
   PubMed Web of Science ®Google Scholar
• XingBXinTHunterRLBingGPioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/AktJ Neuroinflammation20085411118171484
   PubMed Web of Science ®Google Scholar
• GiovanniniMGScaliCProsperiCβ-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathwayNeurobiol Dis200211225727412505419
   PubMed Web of Science ®Google Scholar
• MatosMAugustoEOliveiraCAgostinhoPAmyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascadesNeuroscience2008156489891018790019
   PubMed Web of Science ®Google Scholar
• PawateSBhatNRC-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoformAntioxid Redox Signal200685–690390916771680
   PubMed Web of Science ®Google Scholar
• MarcusJSKarackattuSLFleegalMASumnersCCytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-κBGlia200341215216012509805
   PubMed Web of Science ®Google Scholar
• HanJEChoiJWControl of JNK for an activation of NADPH oxidase in LPS-stimulated BV2 microgliaArch Pharm Res201235470971522553064
   PubMed Web of Science ®Google Scholar
• YenkiPKhodagholiFShaerzadehFInhibition of phosphorylation of JNK suppresses A beta-induced ER stress and upregulates pro-survival mitochondrial proteins in rat hippocampusJ Mol Neurosci201349226226922706709
   PubMed Web of Science ®Google Scholar
• LuD-YLeungY-MSuK-PInterferon-alpha induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-alpha-induced depressionInt J Neuropsychopharmacol201316243344422717332
   PubMed Web of Science ®Google Scholar
• XingBBachstetterADVan EldikLJDeficiency in p38beta MAPK fails to inhibit cytokine production or protect neurons against inflammatory insult in in vitro and in vivo mouse modelsPloS One201382e56852e5685223457629
   PubMed Web of Science ®Google Scholar
• ChangLJonesYEllismanMHGoldsteinLSKarinMJNK1 is required for maintenance of neuronal microtubules and controls phos-phorylation of microtubule-associated proteinsDev Cell20034452153312689591
   PubMed Web of Science ®Google Scholar
• KelleherIGarwoodCHangerDPAndertonBHNobleWKinase activities increase during the development of tauopathy in htau miceJ Neurochem200710362256226717908241
   PubMed Web of Science ®Google Scholar
• LeeJWLeeYKBanJOGreen tea (−)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappa B pathways in miceJ Nutr2009139101987199319656855
   PubMed Web of Science ®Google Scholar
• KimSJJeongHJLeeKMEpigallocatechin-3-gallate suppresses NF-kappa B activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cellsJ Nutr Biochem200718958759617446059
   PubMed Web of Science ®Google Scholar
• JanaMDasguptaSLiuXPahanKRegulation of tumor necrosis factor-α expression by CD40 ligation in BV-2 microglial cellsJ Neurochem200280119720611796758
   PubMed Web of Science ®Google Scholar
• NakajimaKMatsushitaYTohyamaYKohsakaSKuriharaTDifferential suppression of endotoxin-inducible inflammatory cytokines by nuclear factor kappa B (NFκB) inhibitor in rat microgliaNeurosci Lett2006401319920216580131
   PubMed Web of Science ®Google Scholar
• BhatNRFeinsteinDLShenQBhatANp38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells roles of nuclear factors, nuclear factor κB, cAMP response element-binding protein, CCAAT/enhance-binding protein-β, and activating transcription factor-2J Biol Chem200227733295842959212048217
   PubMed Web of Science ®Google Scholar
• DaiY-QJinD-ZZhuX-ZLeiD-LTriptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytesNeurosci Res200655215416016600409
   PubMed Web of Science ®Google Scholar
• CombsCKJohnsonDEKarloJCCannadySBLandrethGEInflammatory mechanisms in Alzheimer’s disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonistsJ Neurosci200020255856710632585
   PubMed Web of Science ®Google Scholar
• LandrethGJiangQMandrekarSHenekaMPPARγ agonists as therapeutics for the treatment of Alzheimer’s diseaseNeurothera-peutics200853481489
   PubMed Web of Science ®Google Scholar
• SenRBaltimoreDMultiple nuclear factors interact with the immunoglobulin enhancer sequencesCell19864657057163091258
   PubMed Web of Science ®Google Scholar
• HaydenMSGhoshSShared principles in NF-κB signalingCell2008132334436218267068
   PubMed Web of Science ®Google Scholar
• Mincheva-TashevaSSolerRMNF-κB signaling pathways role in nervous system physiology and pathologyNeuroscientist201319217519422785105
   PubMed Web of Science ®Google Scholar
• PugazhenthiSZhangYBouchardRMahaffeyGInduction of an inflammatory loop by interleukin-1 beta and tumor necrosis factor-alpha involves NF-kappa B and STAT-1 in differentiated human neuroprogenitor cellsPLoS One201387e6958523922745
   PubMed Web of Science ®Google Scholar
• MirMTolosaLAsensioVJLladóJOlmosGComplementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generationJ Neuroimmunol2008204110110918703234
   PubMed Web of Science ®Google Scholar
• KooJWRussoSJFergusonDNestlerEJDumanRSNuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behaviorProc Natl Acad Sci U S A201010762669267420133768
   PubMed Web of Science ®Google Scholar
• YamamotoYGaynorRBTherapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancerJ Clin Invest2001107213514211160126
   PubMed Web of Science ®Google Scholar
• BargerSWMattsonMPInduction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer’s β-amyloid precursorMol Brain Res19964011161268840019
   PubMedGoogle Scholar
• Buggia-PrevotVSevalleJRossnerSCheclerFNFκB-dependent control of BACE1 promoter transactivation by Aβ42J Biol Chem200828315100371004718263584
   PubMed Web of Science ®Google Scholar
• ValerioABoroniFBenareseMNF-κB pathway: a target for preventing β-amyloid (Aβ)-induced neuronal damage and Aβ42 productionEur J Neurosci20062371711172016623827
   PubMed Web of Science ®Google Scholar
• ChenCHZhouWLiuSIncreased NF-kappa B signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s diseaseInt J Neuropsychopharmacol2012151779021329555
   PubMed Web of Science ®Google Scholar
• NiuYLZhangWJWuPExpression of the apoptosis-related proteins caspase-3 and NF-κB in the hippocampus of Tg2576 miceNeurosci Bull2010261374620101271
   PubMed Web of Science ®Google Scholar
• ChamiLBuggia-PrévotVDuplanENuclear factor-kappa B regulates beta APP and beta- and gamma-secretases differently at physiological and supraphysiological A beta concentrationsJ Biol Chem201228729245732458422654105
   PubMed Web of Science ®Google Scholar
• ParisDPatelNQuadrosAInhibition of Aβ production by NF-κB inhibitorsNeurosci Lett20074151111617223266
   PubMed Web of Science ®Google Scholar
• SungSYangHUryuKModulation of nuclear factor-κB activity by indomethacin influences Aβ levels but not Aβ precursor protein metabolism in a model of Alzheimer’s diseaseAm J Pathol200416562197220615579461
   PubMed Web of Science ®Google Scholar
• AscolaniABalestrieriEMinutoloADysregulated NF-kappa B pathway in peripheral mononuclear cells of Alzheimer’s disease patientsCurr Alzheimer Res20129112813721592054
   PubMed Web of Science ®Google Scholar
• KummerMPHenekaMTPPARs in Alzheimer’s diseasePPAR Res2008200840389618645613
   PubMed Web of Science ®Google Scholar
• KerstenSPeroxisome proliferator activated receptors and lipoprotein metabolismPPAR Res2007200813296018288277
   PubMed Web of Science ®Google Scholar
• BensingerSJTontonozPIntegration of metabolism and inflammation by lipid-activated nuclear receptorsNature2008454720347047718650918
   PubMed Web of Science ®Google Scholar
• BookoutALJeongYDownesMYuRTEvansRMMangelsdorfDJAnatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional networkCell2006126478979916923397
   PubMed Web of Science ®Google Scholar
• de la MonteSMWandsJRMolecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer’s diseaseJ Alzheimer Dis200692167181
   PubMed Web of Science ®Google Scholar
• ChenYCWuJSTsaiHDPeroxisome proliferator-activated receptor gamma (PPAR-gamma) and neurodegenerative disordersMol Neurobiol201246111412422434581
   PubMed Web of Science ®Google Scholar
• WadaKNakajimaAKatayamaKPeroxisome proliferator-activated receptor γ-mediated regulation of neural stem cell proliferation and differentiationJ Biol Chem200628118126731268116524877
   PubMed Web of Science ®Google Scholar
• BrightJJKanakasabaiSChearwaeWChakrabortySPPAR regulation of inflammatory signaling in CNS diseasesPPAR Res2008200865852018670616
   PubMed Web of Science ®Google Scholar
• EspositoGScuderiCValenzaMCannabidiol reduces Ab-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR gamma involvementPLoS One2011612e2866822163051
   PubMed Web of Science ®Google Scholar
• LandrethGTherapeutic use of agonists of the nuclear receptor PPAR in Alzheimers diseaseCurr Alzheimer Res20074215916417430241
   PubMed Web of Science ®Google Scholar
• NeumannKFRojoLNavarreteLPFaríasGReyesPMaccioniRBInsulin resistance and Alzheimer’s disease: molecular links clinical implicationsCurr Alzheimer Res20085543844718855585
   PubMed Web of Science ®Google Scholar
• JiangQHenekaMLandrethGEThe role of peroxisome proliferator-activated receptor-γ PPARγ) in Alzheimer’s diseaseCNS Drugs200822111418072811
   PubMed Web of Science ®Google Scholar
• ZolezziJMSilva-AlvarezCOrdenesDPeroxisome proliferator-activated receptor (PPAR) gamma and PPAR alpha agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?PLoS One201385e6401923675519
   PubMed Web of Science ®Google Scholar
• HenekaMTSastreMDumitrescu-OzimekLAcute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic miceBrain200512861442145315817521
   PubMed Web of Science ®Google Scholar
• GrayEGintyMKempKScoldingNWilkinsAThe PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal functionJ Neuroinflammation201259
   Google Scholar
• d’AbramoCRicciarelliRPronzatoMADaviesPTroglitazone, a peroxisome proliferator-activated receptor-γ agonist, decreases tau phosphorylation in CHOtau4R cellsJ Neurochem20069841068107716787414
   PubMed Web of Science ®Google Scholar
• WangGNamuraSEffects of chronic systemic treatment with peroxisome proliferator-activated receptor alpha activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult miceNeurosci Res201170223023721300114
   PubMed Web of Science ®Google Scholar
• SchneggCIKooshkiMHsuF-CSuiGRobbinsMEPPAR delta prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-kappa B and inhibition of the PK alpha/MEK1/2/ERK1/2/AP-1 pathwayFree Radic Biol Med20125291734174322387176
   PubMed Web of Science ®Google Scholar
• BarrosoEdel ValleJPorquetDTau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPAR beta/delta-null miceBiochim Biophys Acta2013183281241124823507144
   PubMed Web of Science ®Google Scholar
• SharmaVThakurVSinghSNGuleriaRTumor necrosis factor and Alzheimer’s disease: a cause and consequence relationshipKlinik Psikofarmakoloji B20122218697
   Google Scholar
• SwardfagerWLanctôtKRothenburgLWongACappellJHerrmannNA meta-analysis of cytokines in Alzheimer’s diseaseBiol Psychiatry2010681093094120692646
   PubMed Web of Science ®Google Scholar
• Gezen-AkDDursunEHanağasıHBDNF, TNF alpha, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer’s disease or mild cognitive impairmentJ Alzheimers Dis201337118519523948885
   PubMed Web of Science ®Google Scholar
• McAlpineFELeeJKHarmsASInhibition of soluble TNF signaling in a mouse model of Alzheimer’s disease prevents pre-plaque amyloid-associated neuropathologyNeurobiol Dis200934116317719320056
   PubMed Web of Science ®Google Scholar
• YamamotoMKiyotaTHoribaMInterferon-γ and tumor necrosis factor-α regulate amyloid-β plaque deposition and β-secretase expression in Swedish mutant APP transgenic miceAm J Pathol2007170268069217255335
   PubMed Web of Science ®Google Scholar
• LiaoY-FWangB-JChengH-TKuoL-HWolfeMSTumor necrosis factor-α, interleukin-1β, and interferon-γ stimulate γ-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathwayJ Biol Chem200427947495234953215347683
   PubMed Web of Science ®Google Scholar
• TweedieDFergusonRAFishmanKTumor necrosis factor-alpha synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s diseaseJ Neuroinflammation2012299
   Google Scholar
• UsluSAkarkarasuZEOzbabalikDLevels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer’s disease and vascular dementiaNeurochem Res20123771554155922437436
   PubMed Web of Science ®Google Scholar
• KornmanKSInterleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of agingAm J Clin Nutr2006832475S483S16470016
   PubMed Web of Science ®Google Scholar
• HonmaTHattaKHitomiYIncreased systemic inflammatory interleukin-1 beta and interleukin-6 during agitation as predictors of Alzheimer’s diseaseInt J Geriatr Psychiatry201328323324122535710
   PubMed Web of Science ®Google Scholar
• PayãoSLGonçalvesGMde LabioRWAssociation of interleukin 1 beta polymorphisms and haplotypes with Alzheimer’s diseaseJ Neuroimmunol20122471–2596222498095
   PubMed Web of Science ®Google Scholar
• RogersJTLeiterLMMcPheeJTranslation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequencesJ Biol Chem1999274106421643110037734
   PubMed Web of Science ®Google Scholar
• LiuLAboudOJonesRAMrakREGriffinSBargerSWApolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factorsJ Neuroinflammation2011817522171672
   PubMed Web of Science ®Google Scholar
• ShengJGJonesRAZhouXQInterleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer’s disease: potential significance for tau protein phosphorylationNeurochem Int200139534134811578769
   PubMed Web of Science ®Google Scholar
• GriffinWSTLiuLLiYMrakREBargerSWInterleukin-1 mediates Alzheimer and Lewy body pathologiesJ Neuroinflammation200631516542445
   PubMed Web of Science ®Google Scholar
• GhoshSWuMDShaftelSSSustained interleukin-1 beta overexpression exacerbates tau pathology despite reduced Amyloid burden in an Alzheimer’s mouse modelJ Neurosci201333115053506423486975
   PubMed Web of Science ®Google Scholar
• HeinAMStutzmanDLBlandSTProstaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampusNeuroscience2007150475476318035502
   PubMed Web of Science ®Google Scholar
• HeinAMStaskoMRMatousekSBSustained hippocampal IL-1β overexpression impairs contextual and spatial memory in transgenic miceBrain Behav Immun201024224325319825412
   PubMed Web of Science ®Google Scholar
• MatousekSBGhoshSShaftelSSKyrkanidesSOlschowkaJAO’BanionMKChronic IL-1 beta-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer’s disease without inducing overt neurodegenerationJ Neuroimmune Pharmacol20127115616422173340
   PubMed Web of Science ®Google Scholar
• ErtaMQuintanaAHidalgoJInterleukin-6, a major cytokine in the central nervous systemInt J Biol Sci2012891254126623136554
   PubMed Web of Science ®Google Scholar
• SerrettiAOlgiatiPDe RonchiDGenetics of Alzheimer’s disease. A rapidly evolving fieldJ Alzheimer Dis20071217392
   Web of Science ®Google Scholar
• ChenSYChenTFLaiLCSequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer’s diseaseJ Neuroinflammation2012249
   Google Scholar
• QiH-PQuZ-YDuanS-RWeiS-QWenS-RBiSIL-6-174 G/C and-572 C/G polymorphisms and risk of Alzheimer’s diseasePLoS One201276e3785822701584
   PubMed Web of Science ®Google Scholar
• QuerfurthHWLaFerlaFMMechanisms of diseaseN Engl J Med2010362432934420107219
   PubMed Web of Science ®Google Scholar
• QuintanillaRAOrellanaDIGonzález-BillaultCMaccioniRBInterleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathwayExp Cell Res2004295124525715051507
   PubMed Web of Science ®Google Scholar
• HuaYGuoXHuangQKongYLuXAssociation between interleukin-6-174G/C polymorphism and the risk of Alzheimer’s disease: a meta-analysisInt J Neurosci2013123962663523510010
   PubMed Web of Science ®Google Scholar
• SzczepanikAMFunesSPetkoWRingheimGEIL-4, IL-10 and IL-13 modulate Aβ (1–42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell lineJ Neuroimmunol20011131496211137576
   PubMed Web of Science ®Google Scholar
• TownTLaouarYPittengerCBlocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathologyNat Med200814668168718516051
   PubMed Web of Science ®Google Scholar
• KimJOnsteadLRandleSAbeta40 inhibits amyloid deposition in vivoJ Neurosci200727362763317234594
   PubMed Web of Science ®Google Scholar
• LeungRProitsiPSimmonsAInflammatory proteins in plasma are associated with severity of Alzheimer’s diseasePLoS One201386e6497123762274
   PubMed Web of Science ®Google Scholar
• DobolyiAVinczeCPalGLovasGThe neuroprotective functions of transforming growth factor beta proteinsInt J Mol Sci20121378219825822942700
   PubMed Web of Science ®Google Scholar
• RotaEBelloneGRoccaPBergamascoBEmanuelliGFerreroPIncreased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patientsNeurol Sci2006271333916688597
   PubMed Web of Science ®Google Scholar
• MottaMImbesiRDi RosaMStivalaFMalaguarneraLAltered plasma cytokine levels in Alzheimer’s disease: correlation with the disease progressionImmunol Lett20071141465117949824
   PubMed Web of Science ®Google Scholar
• MorimotoKHorioJSatohHExpression profiles of cytokines in the brains of Alzheimer’s disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathologyJ Alzheimer Dis20112515976
   Web of Science ®Google Scholar
• LifshitzVWeissRBenromanoTImmunotherapy of cerebrovascular amyloidosis in a transgenic mouse modelNeurobiol Aging2012332e431e432
   Web of Science ®Google Scholar
• HuangLJiaJLiuRDecreased serum levels of the angiogenic factors VEGF and TGF-beta1 in Alzheimer’s disease and amnestic mild cognitive impairmentNeurosci Lett2013550606323827227
   PubMed Web of Science ®Google Scholar
• MocaliACedrolaSDella MalvaNIncreased plasma levels of soluble CD40, together with the decrease of TGFβ1, as possible differential markers of Alzheimer diseaseExp Gerontol200439101555156115501026
   PubMed Web of Science ®Google Scholar
• KhouryJELusterADMechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implicationsTrends Pharmacol Sci2008291262663218835047
   PubMed Web of Science ®Google Scholar
• CaraciFSpampinatoSSortinoMADysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotectionCell Tissue Res2012347129130121879289
   PubMed Web of Science ®Google Scholar
• MaDDoiYJinSTGF-beta induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid beta neurotoxicityNeurosci Lett20125291869122985514
   PubMed Web of Science ®Google Scholar
• TichauerJEvon BernhardiRTransforming growth factor-beta stimulates beta amyloid uptake by microglia through Smad3-dependent mechanismsJ Neurosci Res201290101970198022715062
   PubMed Web of Science ®Google Scholar
• WeissRLifshitzVFrenkelDTGF-β1 affects endothelial cell interaction with macrophages and T-cells leading to the development of cerebrovascular amyloidosisBrain Behav Immun20112551017102421112386
   PubMed Web of Science ®Google Scholar
• Martinez-CanabalAWheelerALSarkisDChronic over-expression of TGF beta 1 alters hippocampal structure and causes learning deficitsHippocampus201323121198121123804429
   PubMed Web of Science ®Google Scholar
• CitronMAlzheimer’s disease: strategies for disease modificationNat Rev Drug Discov20109538739820431570
   PubMed Web of Science ®Google Scholar
• De StrooperBVassarRGoldeTThe secretases: enzymes with therapeutic potential in Alzheimer diseaseNat Rev Neurol2010629910720139999
   PubMed Web of Science ®Google Scholar
• ThalDRvon ArnimCGriffinWSPathology of clinical and preclinical Alzheimer’s diseaseEur Arch Psychiatry Clin Neurosci2013263S137S14524077890
   PubMed Web of Science ®Google Scholar
• PalopJJMuckeLAmyloid-[beta]-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networksNat Neurosci201013781281820581818
   PubMed Web of Science ®Google Scholar
• VincentAJGasperiniRFoaLSmallDHAstrocytes in Alzheimer’s disease: emerging roles in calcium dysregulation and synaptic plasticityJ Alzheimers Dis201022369971420847426
   PubMed Web of Science ®Google Scholar
• Carrillo-MoraPLunaRColin-BarenqueLAmyloid beta: multiple mechanisms of toxicity and only some protective effects?Oxid Med Cell Longev2014201479537524683437
   PubMed Web of Science ®Google Scholar
• ZotovaEBharambeVCheaveauMInflammatory components in human Alzheimer’s disease and after active amyloid-beta(42) immunizationBrain20131362677269623943781
   PubMed Web of Science ®Google Scholar
• Joseph-MathurinNDorieuxOTroucheSGAmyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleedsNeurobiol Aging201334112613262223796662
   PubMed Web of Science ®Google Scholar
• PanzaFLogroscinoGImbimboBPSolfrizziVIs there still any hope for amyloid-based immunotherapy for Alzheimer’s disease?Curr Opin Psychiatry201427212813724445401
   PubMed Web of Science ®Google Scholar
• CohenTJGuoJLHurtadoDEThe acetylation of tau inhibits its function and promotes pathological tau aggregationNat Commun2011225221427723
   PubMed Web of Science ®Google Scholar
• IqbalKLiuFGongC-XGrundke-IqbalITau in Alzheimer disease and related tauopathiesCurr Alzheimer Res20107865620678074
   PubMed Web of Science ®Google Scholar
• MinSWChoSHZhouYAcetylation of tau inhibits its degradation and contributes to tauopathyNeuron201067695396620869593
   PubMed Web of Science ®Google Scholar
• MorrisMMaedaSVosselKMuckeLThe many faces of tauNeuron201170341042621555069
   PubMed Web of Science ®Google Scholar
• PoolerAMNobleWHangerDPA role for tau at the synapse in Alzheimer’s disease pathogenesisNeuropharmacology2014761824076336
   PubMed Web of Science ®Google Scholar
• ArnaudLRobakisNKFigueiredo-PereiraMEIt may take inflammation, phosphorylation and ubiquitination to “tangle” in Alzheimer’s diseaseNeurodegener Dis20063631331916954650
   PubMed Web of Science ®Google Scholar
• LeeVMGoedertMTrojanowskiJQNeurodegenerative tauopathiesAnnu Rev Neurosci20012411121115911520930
   PubMed Web of Science ®Google Scholar
• Rozenstein-TsalkovichLGrigoriadisNLourbopoulosARepeated immunization of mice with phosphorylated-tau peptides causes neuroinflammationExp Neurol201324845145623876516
   PubMed Web of Science ®Google Scholar
• AnandRGillKDMahdiAATherapeutics of Alzheimer’s disease: past, present and futureNeuropharmacology201476275023891641
   PubMed Web of Science ®Google Scholar